forum semaglutide Troubling Findings in Study of GLP-1 Compounders Some people are overdosing on

However, they should be used with caution in patients with advanced liver disease due to the risk of hyperkalemia and renal dysfunction [150]

#Hypertension #FDAApproval #Cardiology #PrecisionMedicine #MedicalEducation #Pharma #ClinicalTrials #CardioRenal #Animedix #ResistantHypertension To view or add a comment, sign in This week, the FDA approved Baxfendy (baxdrostat) the first aldosterone synthase inhibitor for uncontrolled or treatment-resistant hypertension

A large real-world study shows that patients who stop popular GLP-1based weight-loss drugs often return to treatment or try alternative therapies, helping explain why average weight regain after discontinuation may be smaller than expected

Simple enough on paper

1.Public Health Agency of Canada

223 An in vitro model in which organoids from clinical CRC tissue were mixed with TILs from patients and F